EMILY GEISER: Open Payments
NPI 1134731144 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,978 in 144 payments from 32 companies in 2025. Trend: 2023 $263 · 2024 $2,710 · 2025 $2,978
Food & beverage: $2,978
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 21 | $488 |
| Novo Nordisk Inc | 28 | $294 |
| Amgen Inc. | 13 | $259 |
| Sequel Med Tech, LLC | 4 | $177 |
| RECORDATI_RARE_DISEASES_INC. | 8 | $155 |
| Dexcom, Inc. | 8 | $150 |
| Tandem Diabetes Care, Inc. | 8 | $147 |
| SANOFI-AVENTIS U.S. LLC | 5 | $145 |
| AstraZeneca Pharmaceuticals LP | 3 | $143 |
| Corcept Therapeutics | 5 | $108 |
Products named: EVENITY, TWIIST, Ozempic, ISTURISA, Dexcom G6 Transmitter, t:slim X2 Insulin Pump with Control-IQ, TZIELD, FARXIGA.
Industry payments across AZ — which companies pay providers there.
